Milestone Pharmaceuticals (MIST)

• Market cap: $246M
• 1 day: -5%
• 5 days: 1.95%
• 1 month: 23.67%
• 3 months: 1.95%
• 6 months: 6.09%
• Year to date: 1.95%
• 1 year: 155.81%
• 5 years: -60.57%
• 10 years: -86.4%
• Sector: Healthcare
• Industry: Biotechnology

About: Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Employees: 38